Maxwell Biomedical is developing a therapeutic device capable of delivering imperceptible left atrial resynchronization therapy to restore and maintain a normal heart rhythm in patients suffering from Atrial Fibrillation (AF).
Creating a fully Integrated AF Care System:
– Continuous monitoring, AF detection and imperceptible AF termination
Company’s Keywords:
<12
<
<2019